Menu
0
Total price
0 €
PRICES include / exclude VAT
Homepage>BS ISO 14117:2019 Active implantable medical devices. Electromagnetic compatibility. EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices
Sponsored link
sklademVydáno: 2019-09-04
BS ISO 14117:2019 Active implantable medical devices. Electromagnetic compatibility. EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices

BS ISO 14117:2019

Active implantable medical devices. Electromagnetic compatibility. EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices

Format
Availability
Price and currency
Anglicky Secure PDF
Immediate download
384.29 €
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
38.43 €
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
115.29 €
Anglicky Hardcopy
In stock
384.29 €
Označení normy:BS ISO 14117:2019
Počet stran:146
Vydáno:2019-09-04
ISBN:978 0 580 99091 5
Status:Standard
DESCRIPTION

BS ISO 14117:2019


This standard BS ISO 14117:2019 Active implantable medical devices. Electromagnetic compatibility. EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics
  • 33.100.01 Electromagnetic compatibility in general

This document specifies test methodologies for the evaluation of the electromagnetic compatibility (EMC) of active implantable cardiovascular devices that provide one or more therapies for bradycardia, tachycardia and cardiac resynchronization in conjunction with transvenous lead systems.

NOTE

This document was designed for pulse generators used with endocardial leads or epicardial leads. At the time of this edition, the authors recognized the emergence of technologies that do not use endocardial leads or epicardial leads for which adaptations of this part will be required. Such adaptations are left to the discretion of manufacturers incorporating these technologies.

It specifies performance limits of these devices, which are subject to interactions with EM emitters operating across the EM spectrum in the two following ranges:

  • 0 Hz ?  ƒ < 385 MHz;

  • 385 MHz ?  ƒ ? 3 000 MHz

This document also specifies requirements for the protection of these devices from EM fields encountered in a therapeutic environment and defines their required accompanying documentation, providing manufacturers of EM emitters with information about their expected level of immunity.